Viewing Study NCT07051603


Ignite Creation Date: 2025-12-24 @ 7:11 PM
Ignite Modification Date: 2025-12-28 @ 1:56 PM
Study NCT ID: NCT07051603
Status: RECRUITING
Last Update Posted: 2025-07-04
First Post: 2025-06-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: SAL0140 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population
Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2025-06-09
Start Date Type: ACTUAL
Primary Completion Date: 2026-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-02
Completion Date Type: ESTIMATED
First Submit Date: 2025-06-17
First Submit QC Date: None
Study First Post Date: 2025-07-04
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-07-03
Last Update Post Date: 2025-07-04
Last Update Post Date Type: ACTUAL